Menu
Recruiting NCT05407857

Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention

No phase Interventional Dementia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: multi-modal non-pharmacological intervention.
Who it may be relevant to
Registry conditions: Dementia. Basic parameters: 60 years — 90 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention (TaiPEI)

Overview

A 3-arm randomized controlled trial of multi-modal non-pharmacological Intervention for preventing the risk of dementia in Taiwanese geriatric people

Detailed description

This project proposes an intervention program for dementia prevention based on the Taiwanese model. The investigator(s) will screen the elderly who are not yet demented but are at high risk of dementia and will randomly allocate them into three groups (on site intervention group, remote intervention group, and control group) for a two-year multi-modal non-pharmacological intervention. All intervention groups will be actively involved in management with nutrition, exercise and cognitive programs. The on-site intervention group requires subjects to participate in prescribed place according to the protocol. The remote intervention group is designed for reducing the chances of person-to-person contact response to the current coronavirus disease 2019 (COVID-19) pandemic and development of digital internet. It uses innovative technology combining wearable devices with inertial measurement units, blue-tooth equipment, apps, feedback technology and artificial intelligence based remote comprehensive training programs. During the study period, each group will be regularly monitored the changes of cardiovascular risk factors, physical performance and cognitive function. The results of multimodal intervention mainly from Taipei and New Taipei City will establish the Taiwan FINGER model (TaiPEI) and will have the information of the conditions and feasibility achieved in Taiwan and implementation suggestions in the face of the epidemic. It can be subsequently applied to the brain/body health care institution and to the prevention of dementia and cardiovascular disease of elderly.

Interventions

  • Behavioral multi-modal non-pharmacological intervention
    multi-modal non-pharmacological intervention including the management with nutrition, exercise and cognitive programs

Primary outcome measures

  • Change in cognition including individual cognitive domains, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
Secondary outcome measures (12)
  • Change in physical assessment, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change in physical assessment, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change in physical assessment, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change in physical functioning - Hand-grip strength, kg [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change of the questionnaire regarding the nutrition, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change of the questionnaire regarding the nutrition, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change of nutrition intake, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change in functioning level, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change in functioning level, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change in functioning level, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change in functioning level, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]
  • Change in functioning level, unit on a scale [Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)]

Eligibility criteria

Inclusion criteria

  • People over 60 without dementia
  • Agree to join the study and sign the consent form
  • The Modified Rankin Scale (MRS) scores between 0-1 points
  • Education level: elementary or higher education (6 years) or can read and write Chinese
  • Very early dementia screening scale (AD-8) < 2, or more than 2 points but without dementia diagnoses after refer to a neurologist.
  • Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) Risk Score: above 8; diagnosed with mild cognitive impairment (MCI) or subjective cognitive decline (SCD) in the past six months.

Exclusion criteria

  • Have been diagnosed with any kind of dementia
  • Suspected dementia patients or others who are not suitable to participate in the research assessed by a doctor at the first visit
  • Diseases affecting the safety of various interventional activities (such as remaining life less than two years, symptomatic heart/cerebrovascular disease within 6 months, vascular reperfusion or reconstruction-related surgery within one year, etc., malignant tumor within one year)
  • Severe blindness, hearing or communication impairment, or other difficulty in cooperating or completing assessments and interventions (especially exercise) in the study
  • Severe mental illnesses, including major depression disorder, or major neuromusculoskeletal disorders that are not suitable to join the study.
  • Drug or alcohol abuse in the last year
  • Overlapping with other interventional trials at the same time which may affect the evaluation results.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Prevention

Study locations

Taiwan · 1 center
  • Taipei Medical University-Shuang Ho Hospital — New Taipei City

Identifiers

NCT: NCT05407857 · N202112075

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗